{"content":"{\"ClinVarAccession\":{\"@Type\":\"SCV\"},\"AttributeSet\":{\"Attribute\":{\"@Type\":\"AssertionMethod\",\"$\":\"Submitter's publication\"},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"@Source\":\"PubMed\",\"$\":\"21844811\"}}},\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"@Source\":\"PubMed\",\"$\":\"21844811\"}},{\"@Type\":\"general\",\"ID\":{\"@Source\":\"PubMed\",\"$\":\"21844811\"}}],\"StudyDescription\":{\"$\":\"Copy number variation identified through the course of routine clinical cytogenomic testing in postnatal populations. Clinical assertions have been curated as described in Kaminsky et al. 2011.\"},\"Comment\":{\"$\":\"Copy number variation identified through the course of routine clinical cytogenomic testing in postnatal populations. Clinical assertions have been curated as described in Kaminsky et al. 2011.\"}}","id":"SCV000190832","version":2,"variation_id":"160781","variation_archive_id":"VCV000160781","submitter_id":"505240","submission_id":"505240.2014-06-21","internal_id":"346994","assertion_type":"variation to disease","date_created":"2014-11-28","date_last_updated":"2019-04-24","record_status":"current","review_status":"criteria provided, single submitter","local_key":"nsv1067577:copy number gain:See cases:3:SCV000190832","interpretation_description":"Uncertain significance","interpretation_date_last_evaluated":"2011-08-12","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000190832","clinical_assertion_observation_ids":["SCV000190832.0","SCV000190832.1"],"trait_set_id":"16994","rcv_accession_id":"RCV000050939"}
{"content":"{\"ClinVarAccession\":{\"@Type\":\"SCV\"}}","id":"SCV000024774","version":3,"variation_id":"4352","variation_archive_id":"VCV000004352","submitter_id":"3","submission_id":"3.2013-12-16","internal_id":"24774","assertion_type":"variation to disease","date_created":"2011-01-25","date_last_updated":"2019-05-02","record_status":"current","review_status":"no assertion criteria provided","title":"ATL1, ARG415TRP_SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT","local_key":"606439.0007_SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT","interpretation_description":"Pathogenic","interpretation_date_last_evaluated":"2013-06-01","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000024774","clinical_assertion_observation_ids":["SCV000024774.0"],"trait_set_id":"1198","rcv_accession_id":"RCV000004600"}
{"content":"{\"ClinVarAccession\":{\"@Type\":\"SCV\"},\"Interpretation\":{\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"@Source\":\"PubMed\",\"$\":\"28615637\"}},{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"3344762\"}},{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"21965116\"}}]},\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"@Source\":\"PubMed\",\"$\":\"28615637\"}},{\"@Type\":\"general\",\"ID\":{\"@Source\":\"PubMed\",\"$\":\"28615637\"}}],\"Comment\":{\"@Type\":\"public\",\"$\":\"The mutation was identified with targeted resequencing using Ion Ampliseq Custom Panel and Ion PGM Sequencer.\"}}","id":"SCV000328419","version":1,"variation_id":"267450","variation_archive_id":"VCV000267450","submitter_id":"505727","submission_id":"505727.2016-10-25","internal_id":"623989","assertion_type":"variation to disease","date_created":"2016-11-03","date_last_updated":"2019-03-31","record_status":"current","review_status":"no assertion criteria provided","local_key":"NM_020964.2:exon 15;NM_020964.2:exon 17-22|OMIM:242840","submitted_assembly":"GRCh37","interpretation_description":"Pathogenic","interpretation_date_last_evaluated":"2016-08-11","interpretation_comments":["{\"text\":\"Patient, a 2 year-old girl, showed severe developmental delay,hypotonia, hypopigmentation, and high-arched palate. Her last head circumference was 42.5 (-3.4SD). This mutation was confirmed compound geterozygosity.\",\"type\":\"public\"}"],"clinical_assertion_trait_set_id":"SCV000328419","clinical_assertion_observation_ids":["SCV000328419.0"],"trait_set_id":"9271","rcv_accession_id":"RCV000496984"}
{"content":"{\"ClinVarAccession\":{\"@Type\":\"SCV\"},\"AttributeSet\":{\"Attribute\":{\"@Type\":\"AssertionMethod\",\"$\":\"Invitae Variant Classification Sherloc (09022015)\"},\"Citation\":{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"28492532\"}}}}","id":"SCV000551414","version":2,"variation_id":"4352","variation_archive_id":"VCV000004352","submitter_id":"500031","submission_id":"500031.2017-03-14","internal_id":"1064318","assertion_type":"variation to disease","date_created":"2017-04-13","date_last_updated":"2019-05-02","record_status":"current","review_status":"criteria provided, single submitter","local_key":"1003176|MedGen:C2931355","submitted_assembly":"GRCh37","interpretation_description":"Pathogenic","interpretation_date_last_evaluated":"2016-08-31","interpretation_comments":["{\"text\":\"This sequence change replaces arginine with tryptophan at codon 415 of the ATL1 protein (p.Arg415Trp). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs119476050, ExAC 0.001%). This variant has been reported in several individuals affected with hereditary spastic paraplegia (PMID: 20932283, 24451228, 19459885, 16401858). This variant has also been reported to segregate with hereditary spastic paraplegia in several families, however, it has been identified in unaffected family members due to adult onset and incomplete penetrance (PMID: 15184642, 24417445, 23483706, 26671083). ClinVar contains an entry for this variant (Variation ID: 4352). This missense change is located in a region of the ATL1 protein where a significant number of previously reported ATL1 missense mutations are found (PMID: 15596607, 20932283, 25454648, 23483706, 21336785, 19768483). These observations suggest that a previously unreported missense substitution within this region may affect protein function, but experiments have not been done to test this possibility. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: \\\"Deleterious\\\"; PolyPhen-2: \\\"Possibly Damaging\\\"; Align-GVGD: \\\"Class C0\\\"). For these reasons, this variant has been classified as Pathogenic.\",\"type\":\"public\"}"],"clinical_assertion_trait_set_id":"SCV000551414","clinical_assertion_observation_ids":["SCV000551414.0"],"trait_set_id":"1198","rcv_accession_id":"RCV000004600"}
{"content":"{\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"ClinVarAccession\":{\"@Type\":\"SCV\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"23483706\"}},{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"17502470\"}},{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"20932283\"}}]},\"AttributeSet\":{\"Attribute\":{\"@Type\":\"AssertionMethod\",\"$\":\"ambry_reporting_categories_2017\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/r82hsyqe/ambry_reporting_categories_2017.pdf\"}}}}","id":"SCV000244092","version":4,"variation_id":"4352","variation_archive_id":"VCV000004352","submitter_id":"61756","submission_id":"61756.2018-02-08","internal_id":"454546","assertion_type":"variation to disease","date_created":"2015-09-12","date_last_updated":"2019-05-02","record_status":"current","review_status":"criteria provided, single submitter","local_key":"a12785G","submitted_assembly":"GRCh37","interpretation_description":"Likely pathogenic","interpretation_date_last_evaluated":"2014-07-16","interpretation_comments":["{\"text\":\"Lines of evidence used in support of classification: LIKELY POSITIVE: Relevant Alteration(s) Detected\",\"type\":\"public\"}"],"clinical_assertion_trait_set_id":"SCV000244092","clinical_assertion_observation_ids":["SCV000244092.0"],"trait_set_id":"25797","rcv_accession_id":"RCV000190652"}
{"content":"{\"ClinVarAccession\":{\"@Type\":\"SCV\"}}","id":"SCV000041287","version":2,"variation_id":"4352","variation_archive_id":"VCV000004352","submitter_id":"500062","submission_id":"500062.2013-04-30","internal_id":"41287","assertion_type":"variation to disease","date_created":"2011-05-06","date_last_updated":"2019-05-19","record_status":"current","review_status":"no assertion criteria provided","title":"NM_015915.3:c.1243C>T and Spastic Paraplegia 3A","local_key":"NM_015915.3:c.1243C>T_NBK45978","interpretation_description":"pathologic","interpretation_date_last_evaluated":"2010-09-21","interpretation_comments":["{\"text\":\"Converted during submission to Pathogenic.\",\"type\":\"ConvertedByNCBI\"}"],"clinical_assertion_trait_set_id":"SCV000041287","clinical_assertion_observation_ids":["SCV000041287.0"],"trait_set_id":"1198","rcv_accession_id":"RCV000004600"}
{"content":"{\"ClinVarAccession\":{\"@Type\":\"SCV\"},\"AttributeSet\":{\"Attribute\":{\"@Type\":\"AssertionMethod\",\"$\":\"Submitter's publication\"},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"@Source\":\"PubMed\",\"$\":\"21844811\"}}},\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"@Source\":\"PubMed\",\"$\":\"21844811\"}},{\"@Type\":\"general\",\"ID\":{\"@Source\":\"PubMed\",\"$\":\"21844811\"}}],\"StudyDescription\":{\"$\":\"Copy number variation identified through the course of routine clinical cytogenomic testing in postnatal populations. Clinical assertions have been curated as described in Kaminsky et al. 2011.\"},\"Comment\":{\"$\":\"Copy number variation identified through the course of routine clinical cytogenomic testing in postnatal populations. Clinical assertions have been curated as described in Kaminsky et al. 2011.\"}}","id":"SCV000190831","version":2,"variation_id":"160781","variation_archive_id":"VCV000160781","submitter_id":"505243","submission_id":"505243.2014-06-21","internal_id":"346908","assertion_type":"variation to disease","date_created":"2014-11-28","date_last_updated":"2019-04-23","record_status":"current","review_status":"criteria provided, single submitter","local_key":"nsv1067577:copy number gain:See cases:3:SCV000190831","interpretation_description":"Uncertain significance","interpretation_date_last_evaluated":"2011-08-12","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000190831","clinical_assertion_observation_ids":["SCV000190831.0"],"trait_set_id":"16994","rcv_accession_id":"RCV000050939"}
{"id":"SCV000992278","version":2,"internal_id":"1940929","variation_archive_id":"VCV000183316","variation_id":"183316","submitter_id":"3","submission_id":"3.2019-08-20","trait_set_id":"51835","clinical_assertion_trait_set_id":"SCV000992278","clinical_assertion_observation_ids":["SCV000992278.0"],"title":"PDPR, GLY454CYS_VARIANT OF UNKNOWN SIGNIFICANCE","local_key":"617835.0001_VARIANT OF UNKNOWN SIGNIFICANCE","assertion_type":"variation to disease","date_created":"2019-09-07","date_last_updated":"2019-11-11","record_status":"current","review_status":"no assertion criteria provided","interpretation_description":"Uncertain significance","interpretation_date_last_evaluated":"2015-01-13","content":"{\"ClinVarAccession\":{\"@Type\":\"SCV\"}}","interpretation_comments":[]}
{"id":"SCV000822690","version":1,"internal_id":"1594454","variation_archive_id":"VCV000156414","variation_id":"156414","submitter_id":"500031","submission_id":"500031.2018-08-29","rcv_accession_id":"RCV000144484","trait_set_id":"7549","clinical_assertion_trait_set_id":"SCV000822690","clinical_assertion_observation_ids":["SCV000822690.0"],"local_key":"262885|MedGen:C3279738","assertion_type":"variation to disease","date_created":"2018-10-04","date_last_updated":"2019-03-31","submitted_assembly":"GRCh37","record_status":"current","review_status":"criteria provided, single submitter","interpretation_description":"Pathogenic","interpretation_date_last_evaluated":"2017-10-23","content":"{\"ClinVarAccession\":{\"@Type\":\"SCV\"},\"Interpretation\":{\"Citation\":{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"24781758\"}}},\"AttributeSet\":{\"Attribute\":{\"@Type\":\"AssertionMethod\",\"$\":\"Nykamp K et al. (Genet Med 2017)\"},\"Citation\":{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"28492532\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"@Source\":\"PubMed\",\"$\":\"28492532\"}}}","interpretation_comments":["{\"text\":\"This sequence change creates a premature translational stop signal (p.Thr387Argfs*30) in the AP4B1 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs587779388, ExAC 0.03%). This variant has been reported as homozygous in an a single family affected with severe ID, absent speech, microcephaly, growth retardation, and progressive spastic tetraplegia (PMID: 24781758). Loss-of-function variants in AP4B1 are known to be pathogenic (PMID: 22290197, 24700674, 24781758). For these reasons, this variant has been classified as Pathogenic.\",\"type\":\"public\"}"]}
{"id":"SCV000196422","version":2,"internal_id":"383036","variation_archive_id":"VCV000183316","variation_id":"183316","submitter_id":"500184","submission_id":"500184.2019-11-13","trait_set_id":"51835","clinical_assertion_trait_set_id":"SCV000196422","clinical_assertion_observation_ids":["SCV000196422.0"],"local_key":"13DG0274|Global developmental delay|Typical Joubert syndrome MRI findings","assertion_type":"variation to disease","date_created":"2015-03-09","date_last_updated":"2019-12-28","record_status":"current","review_status":"no assertion criteria provided","interpretation_description":"Likely benign","interpretation_date_last_evaluated":"2019-11-13","content":"{\"ClinVarAccession\":{\"@Type\":\"SCV\"},\"Interpretation\":{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"@Source\":\"PubMed\",\"$\":\"27894351\"}}},\"AttributeSet\":[{\"Attribute\":{\"@Type\":\"ModeOfInheritance\",\"$\":\"Autosomal recessive inheritance\"}},{\"Attribute\":{\"@Type\":\"AssertionMethod\",\"$\":\"research\"}}],\"Citation\":{\"@Type\":\"general\",\"ID\":{\"@Source\":\"PubMed\",\"$\":\"25558065\"}}}","interpretation_comments":["{\"text\":\"In the same patient we were able to identify a likely pathogenic variant for Joubert syndrome (TMEM231 NM_001077418.2: c.665â€\\u009011T>C, see PMID: 27894351).\",\"type\":null}"]}
{"id":"SCV000119895","version":1,"internal_id":"337049","variation_archive_id":"VCV000156414","variation_id":"156414","submitter_id":"505251","submission_id":"505251.2014-02-24","rcv_accession_id":"RCV000144484","trait_set_id":"7549","clinical_assertion_trait_set_id":"SCV000119895","clinical_assertion_observation_ids":["SCV000119895.0","SCV000119895.1","SCV000119895.2"],"local_key":"NM_006594.2:c.1160_1161delCA|OMIM:614066","assertion_type":"variation to disease","date_created":"2014-10-07","date_last_updated":"2019-03-31","record_status":"current","review_status":"no assertion criteria provided","interpretation_description":"Pathogenic","interpretation_date_last_evaluated":"2012-01-01","content":"{\"ClinVarAccession\":{\"@Type\":\"SCV\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"21620353\"}},{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"22290197\"}},{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"21440262\"}}]},\"AttributeSet\":{\"Attribute\":{\"@Type\":\"ModeOfInheritance\",\"$\":\"Autosomal recessive inheritance\"}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"@Source\":\"PubMed\",\"$\":\"24781758\"}}}","interpretation_comments":["{\"text\":\"In two siblings who presented with severe ID, absent speech, microcephaly, growth retardation, and progressive spastic tetraplegia we detected the novel homozygous 2 bp deletion c.1159_1160delCA in AP4B1; the mutation was present in the heterozygous state in both parents. The AP4B1-associated phenotype has previously been assigned to spastic paraplegia-47 (SPG47).\",\"type\":\"public\"}"]}
{"id":"SCV000256543","version":1,"internal_id":"478932","variation_archive_id":"VCV000156414","variation_id":"156414","submitter_id":"3","submission_id":"3.2015-11-06","rcv_accession_id":"RCV000144484","trait_set_id":"7549","clinical_assertion_trait_set_id":"SCV000256543","clinical_assertion_observation_ids":["SCV000256543.0"],"title":"AP4B1, 2-BP DEL, 1160CA  _SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE","local_key":"607245.0004_SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE","assertion_type":"variation to disease","date_created":"2015-11-08","date_last_updated":"2019-03-31","record_status":"current","review_status":"no assertion criteria provided","interpretation_description":"Pathogenic","interpretation_date_last_evaluated":"2014-04-30","content":"{\"ClinVarAccession\":{\"@Type\":\"SCV\"}}","interpretation_comments":[]}
{"id":"SCV000742035","version":1,"internal_id":"1445829","variation_archive_id":"VCV000156414","variation_id":"156414","submitter_id":"61756","submission_id":"61756.2018-02-08","rcv_accession_id":"RCV000623767","trait_set_id":"25797","clinical_assertion_trait_set_id":"SCV000742035","clinical_assertion_observation_ids":["SCV000742035.0"],"local_key":"a124778G","assertion_type":"variation to disease","date_created":"2018-04-13","date_last_updated":"2019-03-31","submitted_assembly":"GRCh37","record_status":"current","review_status":"criteria provided, single submitter","interpretation_description":"Pathogenic","interpretation_date_last_evaluated":"2016-11-30","content":"{\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"ClinVarAccession\":{\"@Type\":\"SCV\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"21620353\"}},{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"22290197\"}},{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"24395635\"}},{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"23167973\"}},{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"24700674\"}},{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"23472171\"}},{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"20972249\"}},{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"25552650\"}},{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"19559397\"}},{\"ID\":{\"@Source\":\"PubMed\",\"$\":\"25693842\"}}]},\"AttributeSet\":{\"Attribute\":{\"@Type\":\"AssertionMethod\",\"$\":\"ambry_reporting_categories_2017\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/r82hsyqe/ambry_reporting_categories_2017.pdf\"}}}}","interpretation_comments":["{\"text\":\"Lines of evidence used in support of classification: POSITIVE: Relevant Alteration(s) Detected\",\"type\":\"public\"}"]}
